cerebral adrenoleukodystrophy

Bluebird, winding down in Europe, withdraws another rare disease gene therapy
BioPharma Dive
Thu, 10/21/21 - 11:17 pm
Bluebird Bio
gene therapy
Europe
Skysona
cerebral adrenoleukodystrophy
Bluebird bio Takes Hit with FDA Clinical Hold on Gene Therapy
BioSpace
Mon, 08/9/21 - 11:48 pm
Bluebird Bio
FDA
clinical hold
gene therapy
eli-cel
cerebral adrenoleukodystrophy
Bluebird, with little fanfare, is first to bring a second gene therapy to market
BioPharma Dive
Wed, 07/21/21 - 08:43 pm
Europe
Bluebird Bio
Skysona
cerebral adrenoleukodystrophy
gene therapy
Bluebird Bio Up As Gene Therapy Scores Against Rare Disease
Investors.com
Sat, 03/5/16 - 09:44 am
Bluebird Bio
gene therapy
Lenti-D
cerebral adrenoleukodystrophy